186 related articles for article (PubMed ID: 15755545)
21. Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the beta-amyloid peptide intracellularly in hippocampal and cortical neurons.
Echeverria V; Ducatenzeiler A; Dowd E; Jänne J; Grant SM; Szyf M; Wandosell F; Avila J; Grimm H; Dunnett SB; Hartmann T; Alhonen L; Cuello AC
Neuroscience; 2004; 129(3):583-92. PubMed ID: 15541880
[TBL] [Abstract][Full Text] [Related]
22. Methylmercury induces neuropathological changes with tau hyperphosphorylation mainly through the activation of the c-jun-N-terminal kinase pathway in the cerebral cortex, but not in the hippocampus of the mouse brain.
Fujimura M; Usuki F; Sawada M; Takashima A
Neurotoxicology; 2009 Nov; 30(6):1000-7. PubMed ID: 19666049
[TBL] [Abstract][Full Text] [Related]
23. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
Goedert M; Spillantini MG; Serpell LC; Berriman J; Smith MJ; Jakes R; Crowther RA
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):213-27. PubMed ID: 11260802
[TBL] [Abstract][Full Text] [Related]
24. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
25. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
Conway KA; Harper JD; Lansbury PT
Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558
[TBL] [Abstract][Full Text] [Related]
26. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
Schell H; Hasegawa T; Neumann M; Kahle PJ
Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
[TBL] [Abstract][Full Text] [Related]
27. Alpha-synuclein induces hyperphosphorylation of Tau in the MPTP model of parkinsonism.
Duka T; Rusnak M; Drolet RE; Duka V; Wersinger C; Goudreau JL; Sidhu A
FASEB J; 2006 Nov; 20(13):2302-12. PubMed ID: 17077307
[TBL] [Abstract][Full Text] [Related]
28. Tau-tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP-17 tau-mutant mice.
Xu J; Sato S; Okuyama S; Swan RJ; Jacobsen MT; Strunk E; Ikezu T
FASEB J; 2010 Aug; 24(8):2904-15. PubMed ID: 20354135
[TBL] [Abstract][Full Text] [Related]
29. Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies.
Neumann M; Kahle PJ; Giasson BI; Ozmen L; Borroni E; Spooren W; Müller V; Odoy S; Fujiwara H; Hasegawa M; Iwatsubo T; Trojanowski JQ; Kretzschmar HA; Haass C
J Clin Invest; 2002 Nov; 110(10):1429-39. PubMed ID: 12438441
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic mice.
Casadei N; Pöhler AM; Tomás-Zapico C; Torres-Peraza J; Schwedhelm I; Witz A; Zamolo I; De Heer R; Spruijt B; Noldus LP; Klucken J; Lucas JJ; Kahle PJ; Krüger R; Riess O; Nuber S
Hum Mol Genet; 2014 Feb; 23(3):767-81. PubMed ID: 24064336
[TBL] [Abstract][Full Text] [Related]
31. Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.
Haggerty T; Credle J; Rodriguez O; Wills J; Oaks AW; Masliah E; Sidhu A
Eur J Neurosci; 2011 May; 33(9):1598-610. PubMed ID: 21453448
[TBL] [Abstract][Full Text] [Related]
32. Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease.
Febbraro F; Sahin G; Farran A; Soares S; Jensen PH; Kirik D; Romero-Ramos M
Neurobiol Dis; 2013 Aug; 56():47-58. PubMed ID: 23567651
[TBL] [Abstract][Full Text] [Related]
33. Hyperphosphorylation of Tau and filopodial retraction following microinjection of protein kinase C catalytic subunits.
Cressman CM; Shea TB
J Neurosci Res; 1995 Dec; 42(5):648-56. PubMed ID: 8600297
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of alpha-synuclein characteristic of synucleinopathy lesions is recapitulated in alpha-synuclein transgenic Drosophila.
Takahashi M; Kanuka H; Fujiwara H; Koyama A; Hasegawa M; Miura M; Iwatsubo T
Neurosci Lett; 2003 Jan; 336(3):155-8. PubMed ID: 12505616
[TBL] [Abstract][Full Text] [Related]
35. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease.
Chen L; Feany MB
Nat Neurosci; 2005 May; 8(5):657-63. PubMed ID: 15834418
[TBL] [Abstract][Full Text] [Related]
36. Adaptive responses to alloxan-induced mild oxidative stress ameliorate certain tauopathy phenotypes.
Yoshiike Y; Yamashita S; Mizoroki T; Maeda S; Murayama M; Kimura T; Sahara N; Soeda Y; Takashima A
Aging Cell; 2012 Feb; 11(1):51-62. PubMed ID: 21981382
[TBL] [Abstract][Full Text] [Related]
37. Altered phosphorylation but no neurodegeneration in a mouse model of tau hyperphosphorylation.
Hundelt M; Fath T; Selle K; Oesterwind K; Jordan J; Schultz C; Götz J; von Engelhardt J; Monyer H; Lewejohann L; Sachser N; Bakota L; Brandt R
Neurobiol Aging; 2011 Jun; 32(6):991-1006. PubMed ID: 19660835
[TBL] [Abstract][Full Text] [Related]
38. Early and persistent expression of phosphorylated α-synuclein in the enteric nervous system of A53T mutant human α-synuclein transgenic mice.
Bencsik A; Muselli L; Leboidre M; Lakhdar L; Baron T
J Neuropathol Exp Neurol; 2014 Dec; 73(12):1144-51. PubMed ID: 25383638
[TBL] [Abstract][Full Text] [Related]
39. Progranulin reduction is associated with increased tau phosphorylation in P301L tau transgenic mice.
Hosokawa M; Arai T; Masuda-Suzukake M; Kondo H; Matsuwaki T; Nishihara M; Hasegawa M; Akiyama H
J Neuropathol Exp Neurol; 2015 Feb; 74(2):158-65. PubMed ID: 25575133
[TBL] [Abstract][Full Text] [Related]
40. Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro.
Qureshi HY; Paudel HK
J Biol Chem; 2011 Feb; 286(7):5055-68. PubMed ID: 21127069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
